Mechanisms of HCV reinfection and allograft damage after liver transplantation

Journal of Hepatology

Volumn 40, Issue 3, 2004, Pages 368-374

  McCaughan, Geoffrey W ^a   Zekry, Amany ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ALLOGRAFT; CHIMPANZEE; CHOLESTATIC HEPATITIS; CHRONIC HEPATITIS; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER INJURY; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REINFECTION; REVIEW;

EID: 1242269878     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.01.014     Document Type: Review

References (72)

1. Feray C., Samuel D., Thiers V., Gigou M., Pichon F., Bismuth A., et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 89:1992;1361-1365.
2. McCaughan G.W., Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl. 8:2002;S7-S13.
3. Koziel M.J. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat. 4:1997;31-41.
4. Chen M., Sallberg M., Sonnerborg A., Weiland O., Mattsson L., Jin L., et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology. 116:1999;135-143.
5. Thimme R., Bukh J., Spangenberg H.C., Wieland S., Pemberton J., Steiger C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 99:2002;15661-15668.
6. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.-C., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
7. Missale G., Bertoni R., Lamonaca V., Valli A., Marsari M., Mori C., et al. Different clinical behaviours of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 98:1996;706-714.
8. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 6:2000;578-582.
9. Bigger C.B., Brasky K.M., Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C infection. J Virol. 75:2001;7059.
10. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA. 99:2002;15669-15674.
11. Cerny A., Pape G.R. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis. 181:2000;1528-1536.
12. Cerny A., Chisari F.V. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 30:1999;595-601.
13. Chang K.M., Thimme R., Melpolder J.J., Oldach D., Pemberton J., Mourhead-Loudis J., et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 33:2001;267-276.
14. Rosen H.R., Miner C., Sasaki A.W., Lewinsohn D.M., Conrad A.J., Bakke A., et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 35:2002;190-198.
15. Wedemeyer H., He X.S., Nascimbeni M., Davis A.R., Greenberg H.B., Hoofnagle J.H., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 169:2002;3447-3458.
16. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol. 158:1997;1473-1481.
17. Penna A., Missale G., Lamonca V., Pilli M., Mori C., Zanelli P., et al. Intrahepatic and circulating HLA class 11 restricted hepatitis C virus specific T cells; functional characterisation in patients with chronic hepatitis C. Hepatology. 35:2002;1225-1236.
18. Rico M.A., Quiroga J.A., Subira D., Garcia E., Castanon S., Sallberg M. Features of the T cell response in liver and peripheral blood of hepatitis C virus infected patients with persistently normal and abnormal aminotransferse levels. J Hepatol. 36:2002;408-416.
19. Ando K., Hiroishi K., Kaneko T., Moriyama T., Muto Y., Kayagaki N., et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol. 158:1997;5283-5291.
20. Ruggieri A., Harada T., Matsuura Y., Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virol. 229:1997;68-76.
21. Freeman A.J., Pan Y., Harvey C.E., Post J.J., Law M.G., White P.A., et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol. 38:2003;349-356.
22. Napoli J., Bishop G.A., McGuinness P.H., Painter D.M., McCaughan G.W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of TH1-associated cytokines. Hepatology. 24:1996;759-765.
23. Bertoletti A., D'Elios M.M., Boni C., De Carli M., Zignego A.L., Durazzo M., et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology. 112:1997;193-199.
24. Baroni G.S., Pastorelli A., Manzin A., Benedetti A., Marucci L., Solforosi L., et al. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and TH1-like response in chronic hepatitis C. Liver. 19:1999;212-219.
25. Shields P.L., Morland C.M., Salmon M., Qin S., Hubscher S.G., Adams D.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 163:1999;6236-6243.
26. McGuinness P.H., Painter D., Davies S., McCaughan G.W. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut. 46:2000;260-269.
27. Schirren C.A., Jung M.C., Gerlach J.T., Worzfeld T., Baretton G., Gruener N.H., et al. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognise multiple HCV epitopes and produce interferon gamma. Hepatology. 32:2000;597-603.
28. Shackel N.A., McGuinness P.H., Abbott C.A., Gorrell M.D., McCaughan G.W. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol. 160:2002;641-654.
29. Mihm S., Schweyer S., Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol. 70:2003;562-570.
30. Smith M.W., Yue Z.N., Korth M.J., Do H.A., Boix L., Fausto N., et al. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology. 38:2003;1458-1467.
31. McGuinness P.H., Bishop G.A., Painter D.M., Chan R., McCaughan G.W. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology. 23:1996;676-687.
32. Hui J.M., Sud A., Farrell G.C., Bandara P., Byth K., Kench J.G., et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology. 125:2003;1695-1704.
33. Garcia-Retortillo M., Forns X., Feliu A., Moitinho E., Costa J., Navasa M., et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology. 35:2002;680-687.
34. Lyra C., Fan X., Lang D.M., Yusim K., Ramrakhiani S., Brunt E.M., et al. Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology. 123:2002;1485-1493.
35. Arenas J.I., Khatib M.A., Groninger H., Wilkinson J., Williams J., Mulligan D., et al. Patterns of HCV quasispecies transmission and evolution after liver transplantation predict the severity of recurrence. Hepatology. 36:2002;179A.
36. Ballardini G., De Raffele E., Groff P., Bioulac-Sage P., Grassi A., Ghetti S., et al. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl. 8:2002;10-20.
37. Guerrero R.B., Batts K.P., Burgart L.J., Barrett S.L., Germer J.J., Poterucha J., et al. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation. Mod Pathol. 13:2000;229-237.
38. Gane E.J., Naoumov N.V., Qian K.P., Mondelli M.U., Maertens G., Portmann B.C., et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 110:1996;167-177.
39. Schirren C.A., Jung M.C., Worzfeld T., Mamin M., Baretton G., Gerlach J.T., et al. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalises to the liver and does not correlate with recurrent disease. J Infect Dis. 183:2001;1187-1194.
40. Lim H.L., Lau G.K., Davis G.L., Dolson D.J., Lau J.Y. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology. 106:1994;248-251.
41. Dickson R.C., Caldwell S.H., Ishitani M.B., Lau J.Y., Driscoll C.J., Stevenson W.C., et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation. 61:1996;701-705.
42. Schluger L.K., Sheiner P.A., Thung S.N., Lau J.Y., Min A., Wolf D.C., et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
43. Taga S.A., Washington M.K., Terrault N., Wright T.L., Somberg K.A., Ferrell L.D. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg. 4:1998;304-310.
44. Delladetsima J.K., Boletis J.N., Makris F., Psichogiou M., Kostakis A., Hatzakis A. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg. 5:1999;294-300.
45. Taga S.A., Washington M.K., Terrault N., Wright T.L., Somberg K.A., Ferrell L.D. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg. 4:1998;304-310.
46. Schluger L.K., Sheiner P.A., Thung S.N., Lau J.Y., Min A., Wolf D.C., et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
47. Doughty A.L., Spencer J.D., Cossart Y.E., McCaughan G.W. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg. 4:1998;15-21.
48. Sreekumar R., Gonzalez-Koch A., Maor-Kendler Y., Batts K., Moreno-Luna L., Poterucha J., et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology. 32:2000;1125-1130.
49. Doughty A.L., Painter D.M., McCaughan G.W. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J Hepatol. 32:2000;126-134.
50. Pessoa M.G., Bzowej N., Berenguer M., Phung Y., Kim M., Ferrell L., et al. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology. 30:1999;1513-1520.
51. McCaughan G.W., Doughty A. Post-transplant hepatitis C virus quasispecies and cholestatic hepatitis. Hepatology. 32:2000;1182.
52. Rosen H.R., Hinrichs D.J., Gretch D.R., Koziel M.J., Chou S., Houghton M., et al. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation [see comments]. Gastroenterology. 117:1999;926-932.
53. Zekry A., Bishop G.A., Bowen D.G., Gleeson M.M., Guney S., Painter D.M., et al. Intrahepatic cytokine profiles associated with post-transplantation hepatitis C virus-related liver injury. Liver Transpl. 8:2002;292-301.
54. Milner C., Koziel M.J., Rosen H.R. Intrahepatic and circulating CD4+ T cells after liver transplantation; evidence of compartmentalisation. Hepatology. 34:2002;362A.
55. Schirren C.A., Jung M., Worzfeld T., Mamin M., Baretton G.B., Gruener N.H., et al. Cytokine profile of liver- and blood-derived non-specific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transpl. 6:2000;222-228.
56. Zekry A., Williams R., McCaughan G.W. Microarray analysis of Intrahepatic gene expression in different patterns of HCV recurrence post liver transplant. Hepatology. 38:2003;171A.
57. Crespo J., Rivero M., Mayorga M., Fabrega E., Casafont F., Gomez-Fleitas M., et al. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation. Liver Transpl. 6:2000;562-569.
58. Asanza C.G., Garcia-Monzon C., Clemente G., Salcedo M., Garcia-Buey L., Garcia-Iglesias C., et al. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology. 26:1997;755-763.
59. Di Martino V., Saurini F., Samuel D., Gigou M., Dussaix E., Reynes M., et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology. 26:1997;1343-1350.
60. Stolpman N., Stephens J., Trouillot T., Trotter J., Kugelmas M., Waxhs M. Apparent slowing of hepatitis C recurrence and progression after liver transplantation using very early (14d) steroid withdrawal. Am J Transpl. 2001;177A.
61. Charlton M., Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg. 5:1999;S107-S114.
62. Fang S.H., Hwang L.H., Chen D.S., Chiang B.L. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol. 33:2000;791-798.
63. Papatheodoridis G.V., Barton S.G., Andrew D., Clewley G., Davies S., Dhillon A.P., et al. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens [see comments]. Gut. 45:1999;427-434.
64. Brillanti S., Vivarelli M., De Ruvo N., Aden A.A., Camaggi V., D'Errico A., et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl. 8:2002;884-888.
65. Berenguer M., Crippin J., Gish R., Bass N., Bostrom A., Netto G., et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology. 38:2003;34-41.
66. Nelson D.R., Soldevila-Pico C., Reed A., Abdelmalek M.F., Hemming A.W., Van der Werf W.J., et al. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. Liver Transpl. 7:2001;1064-1070.
67. Fasola C.G., Netto G., Christensen L.L., Rakela J., Thomas M. Lower incidence of early HCV-RNA levels and HCV recurrence post liver transplantation in patients induced with mycophenolate mofetil: a high-dose benefit. Am J Transpl. 2:2002;196.
68. Firpi R.J., Nelson D.R., Davis G.L. Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection. Liver Transpl. 9:2003;57-61.
69. Charlton M.R. Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire? Liver Transpl. 8:2002;47-49.
70. Rostaing L., Izopet J., Sandres K., Cisterne J.M., Puel J., Durand D. Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation. 69:2000;991-994.
71. Zekry A., Gleeson M., Turhan S., McCaughan G.W. The effect of mycophenolate compared to azathioprine on viral load in HCV liver transplant recipients. Liver Transpl. 10:2004;52-58.
72. Report of the first Internal Liver Transplantation Society expert panel consensus conference on liver transplantation on hepatitis C. Liver Transpl 2003;9:S1-S9.